Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

Conditions:   Progression-free Survival;   Overall Survival;   Toxicity Interventions:   Drug: pegylated liposomal doxorubicin;   Drug: pirarubicin Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital;   Chinese PLA General Hospital;   Beijing Jishuitan Hospital;   Xijing Hospital;   Peking Union Medical College Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials